US 7365165
IL-1 antagonist formulations
granted A61KA61K38/1709A61K38/2006
Quick answer
US patent 7365165 (IL-1 antagonist formulations) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/1709, A61K38/2006, A61K47/10, A61K47/183